Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
World
Daniel Keane

Weight loss jabs improve heart failure symptoms in obese patients

Weight loss jabs could improve the symptoms of heart failure in obese patients, a new study has found.

US researchers found that semaglutide – sold under the brand name Wegovy – could be used to treat overweight people with a condition called heart failure with preserved ejection fraction (HFpEF).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.